Related Experiment Video
Updated: Aug 15, 2026

Intrathecal Injection of Newborn Mouse for Genome Editing and Drug Delivery
Published on: March 8, 2024
Once-daily gentamicin dosing of 4 Mg/Kg/dose in neonates
Pakaphan Kiatchoosakun1, Pope Kosalaraksa, Junya Jirapradittha
1Division of Neonatology, Department of Pediatrics, Faculty of Medicine, Khon Kaen University, Khon Kaen 40002, Thailand.
Abstract:
Since gentamicin is one of the most commonly prescribed antibiotics for culture-proven or suspected sepsis in neonates, interest has increased in refining dosing regimens for improved efficacy and decreased toxicity. Usually, 2.5 mg gentamicin/kg is infused twice daily, but its large volume of distribution, slow renal clearance and concentration-dependent character, suggests longer dosing intervals would be more appropriate. From a previous study, 22% of neonates who received a once-daily gentamicin dosage of 5 mg/kg/day had unacceptably high trough levels (i.e. > 2 microg/mL). The authors studied 105 neonates (of > or = 34 wk gestational age or > or = 2, 000 g body weight) admitted to the Neonatal Unit, Srinagarind Hospital, Khon Kaen University; at risk, or with clinical features of sepsis, receiving a once-daily gentamicin dosing of 4 mg/kg intravenously. Peak (i.e. efficacy) and trough (i.e. toxicity) serum gentamicin concentrations were collected on day 3 of therapy. On days 1 and 3, nephrotoxicity was evaluated from serum creatinine and ototoxicity by a hearing test. Neonates treated with 4 mg gentamicin/kg once-daily had a mean steady-state peak vs trough concentration of 7.33 (+/- 2.77) vs 0.99 (+/- 0.57) microg/mL, respectively. The peak serum concentration achieved a therapeutic level > 4 microg/mL in 102 neonates (97%), while 7 (6.67%) had an undesirable trough level (viz. > 2 microg/mL); notwithstanding, no nephrotoxic or ototoxic effects were identified. Gentamicin once-daily at 4 mg/kg/dose in neonates at > or = 34 wk gestation achieved appropriate trough levels. the regimen was convenient and did not increase renal or ototoxicity.
Insights
A once-daily gentamicin dose of 4 mg/kg is effective and safe for neonatal sepsis treatment. This optimized neonatal gentamicin regimen achieved therapeutic peak levels while maintaining safe trough levels, avoiding nephrotoxicity and ototoxicity.
Area of Science:
- Neonatal pharmacology
- Pediatric infectious diseases
- Antibiotic stewardship
Background:
- Gentamicin is a critical antibiotic for neonatal sepsis, but optimal dosing requires balancing efficacy and toxicity.
- Traditional twice-daily dosing may not be ideal due to gentamicin's pharmacokinetic properties in neonates.
- Previous studies indicated potential toxicity with higher once-daily doses.
Purpose of the Study:
- To evaluate the efficacy and safety of a once-daily gentamicin regimen of 4 mg/kg in neonates.
- To determine peak and trough serum gentamicin concentrations.
- To assess for nephrotoxicity and ototoxicity.
Main Methods:
- A study of 105 neonates (gestational age ≥34 wk or weight ≥2,000 g) with suspected or confirmed sepsis.
- Intravenous administration of gentamicin at 4 mg/kg once daily.
- Serum gentamicin concentrations (peak and trough) measured on day 3.
- Nephrotoxicity assessed by serum creatinine and ototoxicity by hearing tests on days 1 and 3.
Main Results:
- Mean steady-state peak concentration was 7.33 µg/mL (therapeutic), and trough concentration was 0.99 µg/mL (safe).
- 97% of neonates achieved therapeutic peak levels (>4 µg/mL).
- Only 6.67% had undesirable trough levels (>2 µg/mL), with no identified nephrotoxic or ototoxic effects.
Conclusions:
- Once-daily gentamicin at 4 mg/kg is effective for neonatal sepsis in neonates ≥34 wk gestation.
- This dosing regimen achieves appropriate trough levels and is convenient.
- The 4 mg/kg once-daily regimen did not increase renal or ototoxicity in the studied neonates.
Related Concept Videos
Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations
Drug Dosing: Infants and Children
Dosage Regimen: Multiple Oral Dosage
IV Infusion to Oral Dosing: Conversion Methods
Dosage Interval and Administration Route: Determination Methods

